[非酒精性脂肪肝的发病机制及潜在治疗靶点] - Suppr

Suppr

超能文献

[Pathogenesis of non-alcoholic fatty liver and potential therapeutic targets].

作者信息

Crespo J, Cayón A, Pons-Romero F

机构信息

Servicio de Aparato Digestivo, Hospital Universitario Marqués de Valdecilla, Santander, España.

出版信息

Gastroenterol Hepatol. 2004 Feb;27 Suppl 1:15-23.

PMID:15195530

Abstract

摘要

相似文献

[Pathogenesis of non-alcoholic fatty liver and potential therapeutic targets].

Gastroenterol Hepatol. 2004 Feb;27 Suppl 1:15-23.

Environmental and genetic determinants of fatty liver in humans.

Dig Dis. 2010;28(1):169-78. doi: 10.1159/000282082. Epub 2010 May 7.

[Patomechanisms of hepatic steatosis].

Orv Hetil. 2010 Feb 28;151(9):323-9. doi: 10.1556/OH.2010.28816.

Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives.

Dig Liver Dis. 2006 Nov;38(11):789-801. doi: 10.1016/j.dld.2006.04.009. Epub 2006 Jun 5.

[Non-alcoholic fatty liver disease].

Ann Pathol. 2010 Dec;30(6):413-20. doi: 10.1016/j.annpat.2010.10.002. Epub 2010 Nov 26.

[Fatty liver and its clinical management in obese adolescents].

Endocrinol Nutr. 2011 Jan;58(1):32-7. doi: 10.1016/j.endonu.2010.10.005. Epub 2011 Jan 7.

Therapeutic strategies in nonalcoholic fatty liver disorders.

Expert Opin Emerg Drugs. 2005 May;10(2):237-9. doi: 10.1517/14728214.10.2.237.

[Role of lipid peroxidation in non-alcoholic steatohepatitis].

Orv Hetil. 2004 Mar 21;145(12):611-8.

[Non-alcoholic fatty liver disease and cardiovascular risk].

Orv Hetil. 2008 Jul 13;149(28):1299-305. doi: 10.1556/OH.2008.28418.

Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance.

Nat Clin Pract Endocrinol Metab. 2006 Jun;2(6):335-48. doi: 10.1038/ncpendmet0190.

引用本文的文献

Tumor necrosis factor-alpha, interleukin-1beta and nitric oxide: induction of liver megamitochondria in prehepatic portal hypertensive rats.

World J Surg. 2005 Jul;29(7):903-8. doi: 10.1007/s00268-005-7757-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Pathogenesis of non-alcoholic fatty liver and potential therapeutic targets].

Gastroenterol Hepatol. 2004 Feb;27 Suppl 1:15-23.

Environmental and genetic determinants of fatty liver in humans.

Dig Dis. 2010;28(1):169-78. doi: 10.1159/000282082. Epub 2010 May 7.

[Patomechanisms of hepatic steatosis].

Orv Hetil. 2010 Feb 28;151(9):323-9. doi: 10.1556/OH.2010.28816.

Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives.

Dig Liver Dis. 2006 Nov;38(11):789-801. doi: 10.1016/j.dld.2006.04.009. Epub 2006 Jun 5.

[Non-alcoholic fatty liver disease].

Ann Pathol. 2010 Dec;30(6):413-20. doi: 10.1016/j.annpat.2010.10.002. Epub 2010 Nov 26.

[Fatty liver and its clinical management in obese adolescents].

Endocrinol Nutr. 2011 Jan;58(1):32-7. doi: 10.1016/j.endonu.2010.10.005. Epub 2011 Jan 7.

Therapeutic strategies in nonalcoholic fatty liver disorders.

Expert Opin Emerg Drugs. 2005 May;10(2):237-9. doi: 10.1517/14728214.10.2.237.

[Role of lipid peroxidation in non-alcoholic steatohepatitis].

Orv Hetil. 2004 Mar 21;145(12):611-8.

[Non-alcoholic fatty liver disease and cardiovascular risk].

Orv Hetil. 2008 Jul 13;149(28):1299-305. doi: 10.1556/OH.2008.28418.

Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance.

Nat Clin Pract Endocrinol Metab. 2006 Jun;2(6):335-48. doi: 10.1038/ncpendmet0190.

引用本文的文献

Tumor necrosis factor-alpha, interleukin-1beta and nitric oxide: induction of liver megamitochondria in prehepatic portal hypertensive rats.

World J Surg. 2005 Jul;29(7):903-8. doi: 10.1007/s00268-005-7757-5.